Movement Disorders, ISSN 0885-3185, 07/2015, Volume 30, Issue 8, pp. 1115 - 1120
Background Tourette syndrome is a disorder characterized by persistent motor and vocal tics, and frequently accompanied by the comorbidities attention deficit...
family‐based association analysis | Tourette syndrome | synaptic neurotransmission | family-based association analysis | NEUROTROPHIC FACTOR | BASAL GANGLIA | CLINICAL NEUROLOGY | OBSESSIVE-COMPULSIVE DISORDER | INDIVIDUALS | BRAIN-STEM PLASTICITY | GABAERGIC INTERNEURONS | MISSING HERITABILITY | LINKAGE | NEURON | GENOME-WIDE ASSOCIATION | Tourette Syndrome - genetics | Genetic Association Studies | Synaptic Transmission - genetics | United States | Humans | Middle Aged | Glial Cell Line-Derived Neurotrophic Factor - genetics | Male | Polymorphism, Genetic | Young Adult | Pedigree | Adolescent | Adult | Female | Child | Cohort Studies | Tourette's syndrome | Medical research | Genes | Attention-deficit hyperactivity disorder | Genetic research | Medicine, Experimental | Genetic aspects
family‐based association analysis | Tourette syndrome | synaptic neurotransmission | family-based association analysis | NEUROTROPHIC FACTOR | BASAL GANGLIA | CLINICAL NEUROLOGY | OBSESSIVE-COMPULSIVE DISORDER | INDIVIDUALS | BRAIN-STEM PLASTICITY | GABAERGIC INTERNEURONS | MISSING HERITABILITY | LINKAGE | NEURON | GENOME-WIDE ASSOCIATION | Tourette Syndrome - genetics | Genetic Association Studies | Synaptic Transmission - genetics | United States | Humans | Middle Aged | Glial Cell Line-Derived Neurotrophic Factor - genetics | Male | Polymorphism, Genetic | Young Adult | Pedigree | Adolescent | Adult | Female | Child | Cohort Studies | Tourette's syndrome | Medical research | Genes | Attention-deficit hyperactivity disorder | Genetic research | Medicine, Experimental | Genetic aspects
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 02/2013, Volume 84, Issue 2, pp. 122 - 129
Objectives To analyse the differences in the clinical features and characteristics of 123I-labelled 2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)...
Dopamine Plasma Membrane Transport Proteins - metabolism | Brain - diagnostic imaging | Tomography, Emission-Computed, Single-Photon - methods | Iodine Radioisotopes | Parkinson Disease - diagnostic imaging | Humans | Middle Aged | Parkinson Disease, Secondary - diagnosis | Male | Cerebrovascular Disorders - metabolism | Functional Neuroimaging - methods | Case-Control Studies | Brain - metabolism | Tropanes | Cerebrovascular Disorders - diagnosis | Cerebrovascular Disorders - diagnostic imaging | Parkinson Disease - diagnosis | Parkinson Disease, Secondary - metabolism | Female | Aged | Parkinson Disease - metabolism | Functional Neuroimaging - statistics & numerical data | Parkinson Disease, Secondary - diagnostic imaging | Tomography, Emission-Computed, Single-Photon - statistics & numerical data
Dopamine Plasma Membrane Transport Proteins - metabolism | Brain - diagnostic imaging | Tomography, Emission-Computed, Single-Photon - methods | Iodine Radioisotopes | Parkinson Disease - diagnostic imaging | Humans | Middle Aged | Parkinson Disease, Secondary - diagnosis | Male | Cerebrovascular Disorders - metabolism | Functional Neuroimaging - methods | Case-Control Studies | Brain - metabolism | Tropanes | Cerebrovascular Disorders - diagnosis | Cerebrovascular Disorders - diagnostic imaging | Parkinson Disease - diagnosis | Parkinson Disease, Secondary - metabolism | Female | Aged | Parkinson Disease - metabolism | Functional Neuroimaging - statistics & numerical data | Parkinson Disease, Secondary - diagnostic imaging | Tomography, Emission-Computed, Single-Photon - statistics & numerical data
Journal Article
Movement Disorders, ISSN 0885-3185, 03/2016, Volume 31, Issue 3, pp. 402 - 405
ABSTRACT Introduction Uric acid is a natural antioxidant, and it has been shown that low levels of uric acid could be a risk factor for the development of PD....
antioxidants | uric acid | biomarkers | progressive supranuclear palsy | Antioxidants | Biomarkers | Uric acid | Progressive supranuclear palsy | OXIDATIVE STRESS | RISK | LONGITUDINAL DATA | PLASMA URATE | NEUROPROTECTION | CLINICAL NEUROLOGY | CEREBROSPINAL-FLUID URATE | MODELS | IDIOPATHIC PARKINSONS-DISEASE | Cross-Sectional Studies | Humans | Middle Aged | Risk Factors | Male | Supranuclear Palsy, Progressive - blood | Uric Acid - urine | Aged, 80 and over | Female | Multiple System Atrophy - blood | Aged | Parkinson Disease - metabolism | Uric Acid - blood | Parkinson Disease - blood | Supranuclear Palsy, Progressive - diagnosis | Analysis | Movement disorders
antioxidants | uric acid | biomarkers | progressive supranuclear palsy | Antioxidants | Biomarkers | Uric acid | Progressive supranuclear palsy | OXIDATIVE STRESS | RISK | LONGITUDINAL DATA | PLASMA URATE | NEUROPROTECTION | CLINICAL NEUROLOGY | CEREBROSPINAL-FLUID URATE | MODELS | IDIOPATHIC PARKINSONS-DISEASE | Cross-Sectional Studies | Humans | Middle Aged | Risk Factors | Male | Supranuclear Palsy, Progressive - blood | Uric Acid - urine | Aged, 80 and over | Female | Multiple System Atrophy - blood | Aged | Parkinson Disease - metabolism | Uric Acid - blood | Parkinson Disease - blood | Supranuclear Palsy, Progressive - diagnosis | Analysis | Movement disorders
Journal Article
4.
Full Text
Aberrant cortical associative plasticity associated with severe adult Tourette syndrome
Movement Disorders, ISSN 0885-3185, 03/2015, Volume 30, Issue 3, pp. 431 - 435
Background Recent studies have shown altered cortical plasticity in adult patients with Tourette syndrome. However, the clinical significance of this finding...
paired associative stimulation | associative plasticity | motor cortex | transcranial magnetic stimulation | Tourette syndrome | Transcranial magnetic stimulation | Associative plasticity | Motor cortex | Paired associative stimulation | SYSTEM | ADHD | TIC SEVERITY | CLINICAL NEUROLOGY | CHILDREN | HUMAN MOTOR CORTEX | INHIBITION | EXCITABILITY | BRAIN-STEM PLASTICITY | DISORDER | SCALE | Transcranial Magnetic Stimulation | Young Adult | Neuronal Plasticity - physiology | Evoked Potentials, Motor - physiology | Tourette Syndrome - pathology | Humans | Middle Aged | Adult | Motor Cortex - physiopathology | Electromyography
paired associative stimulation | associative plasticity | motor cortex | transcranial magnetic stimulation | Tourette syndrome | Transcranial magnetic stimulation | Associative plasticity | Motor cortex | Paired associative stimulation | SYSTEM | ADHD | TIC SEVERITY | CLINICAL NEUROLOGY | CHILDREN | HUMAN MOTOR CORTEX | INHIBITION | EXCITABILITY | BRAIN-STEM PLASTICITY | DISORDER | SCALE | Transcranial Magnetic Stimulation | Young Adult | Neuronal Plasticity - physiology | Evoked Potentials, Motor - physiology | Tourette Syndrome - pathology | Humans | Middle Aged | Adult | Motor Cortex - physiopathology | Electromyography
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, p. e0174644
Parkinson's disease (PD) patients who present with tremor and maintain a predominance of tremor have a better prognosis. Similarly, PD patients with high...
HETEROGENEITY | URATE | PREDICTOR | ATROPHY | MOTOR SUBTYPES | MULTIDISCIPLINARY SCIENCES | PATTERNS | ASSOCIATION | SPECT | PROGRESSION | Dopamine Plasma Membrane Transport Proteins - isolation & purification | Parkinson Disease - diagnostic imaging | Humans | Middle Aged | Male | Molecular Imaging - methods | Postural Balance - genetics | Parkinson Disease - physiopathology | Corpus Striatum - metabolism | Dopamine Plasma Membrane Transport Proteins - genetics | Gait - physiology | Neuropsychological Tests | Adult | Female | Postural Balance - physiology | Uric Acid - blood | Parkinson Disease - blood | Corpus Striatum - diagnostic imaging | Dopamine - metabolism | Gait - genetics | Parkinson's disease | Dopamine | Physiological aspects | Genetic aspects | Uric acid | Research | Diagnosis | Brain | Gait | Gout | Disorders | Cognitive ability | Nervous system | Rigidity | Males | Assaying | Genotype & phenotype | Archives & records | Autopsy | Neurodegeneration | Neostriatum | Longitudinal studies | Damage | Archives | Movement disorders | Stress concentration | Neurodegenerative diseases | Anemia | Single photon emission computed tomography | Studies | Neurology | Learning algorithms | Chemotherapy | Hospitals | Biomarkers | Neuroimaging | Drug abuse | Nuclear medicine | Oxidative stress | Animal models | Parkinsons disease | Atrophy | Lymphocytes | Rodents | Dementia disorders | Degeneration | Paralysis | Age | Autopsies | Akinesia | Neurons | Alcoholism | Diabetes mellitus | Health risks | Immunoproliferative diseases | Environmental factors | Standards | Medicine | Acids | Deterioration | Machine learning | Cancer
HETEROGENEITY | URATE | PREDICTOR | ATROPHY | MOTOR SUBTYPES | MULTIDISCIPLINARY SCIENCES | PATTERNS | ASSOCIATION | SPECT | PROGRESSION | Dopamine Plasma Membrane Transport Proteins - isolation & purification | Parkinson Disease - diagnostic imaging | Humans | Middle Aged | Male | Molecular Imaging - methods | Postural Balance - genetics | Parkinson Disease - physiopathology | Corpus Striatum - metabolism | Dopamine Plasma Membrane Transport Proteins - genetics | Gait - physiology | Neuropsychological Tests | Adult | Female | Postural Balance - physiology | Uric Acid - blood | Parkinson Disease - blood | Corpus Striatum - diagnostic imaging | Dopamine - metabolism | Gait - genetics | Parkinson's disease | Dopamine | Physiological aspects | Genetic aspects | Uric acid | Research | Diagnosis | Brain | Gait | Gout | Disorders | Cognitive ability | Nervous system | Rigidity | Males | Assaying | Genotype & phenotype | Archives & records | Autopsy | Neurodegeneration | Neostriatum | Longitudinal studies | Damage | Archives | Movement disorders | Stress concentration | Neurodegenerative diseases | Anemia | Single photon emission computed tomography | Studies | Neurology | Learning algorithms | Chemotherapy | Hospitals | Biomarkers | Neuroimaging | Drug abuse | Nuclear medicine | Oxidative stress | Animal models | Parkinsons disease | Atrophy | Lymphocytes | Rodents | Dementia disorders | Degeneration | Paralysis | Age | Autopsies | Akinesia | Neurons | Alcoholism | Diabetes mellitus | Health risks | Immunoproliferative diseases | Environmental factors | Standards | Medicine | Acids | Deterioration | Machine learning | Cancer
Journal Article
Journal of Neurology, ISSN 0340-5354, 2014, Volume 261, Issue 3, pp. 561 - 569
The short-term benefits of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson's disease (PD) are well documented, but the long-term...
Long-term | LCIG | Advanced Parkinson's disease | NEUROPATHY | DEMENTIA | DUODENAL LEVODOPA INFUSION | EXPOSURE | CLINICAL NEUROLOGY | AGE | Antiparkinson Agents - pharmacology | Follow-Up Studies | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Gastrostomy - adverse effects | Carbidopa - pharmacology | Levodopa - administration & dosage | Cognition Disorders - etiology | Infusions, Parenteral - methods | Female | Carbidopa - administration & dosage | Cognitive Dysfunction - drug therapy | Severity of Illness Index | Levodopa - pharmacology | Parkinson Disease - complications | Cognition Disorders - physiopathology | Gels | Infusions, Parenteral - adverse effects | Treatment Outcome | Cognition Disorders - drug therapy | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Parkinson Disease - physiopathology | Disease Progression | Neuropsychological Tests | Aged | Antiparkinson Agents - administration & dosage | Drug Combinations | Complications and side effects | Parkinson's disease | Patient outcomes | Dosage and administration | Research | Dopa | Drug therapy
Long-term | LCIG | Advanced Parkinson's disease | NEUROPATHY | DEMENTIA | DUODENAL LEVODOPA INFUSION | EXPOSURE | CLINICAL NEUROLOGY | AGE | Antiparkinson Agents - pharmacology | Follow-Up Studies | Humans | Middle Aged | Male | Parkinson Disease - drug therapy | Gastrostomy - adverse effects | Carbidopa - pharmacology | Levodopa - administration & dosage | Cognition Disorders - etiology | Infusions, Parenteral - methods | Female | Carbidopa - administration & dosage | Cognitive Dysfunction - drug therapy | Severity of Illness Index | Levodopa - pharmacology | Parkinson Disease - complications | Cognition Disorders - physiopathology | Gels | Infusions, Parenteral - adverse effects | Treatment Outcome | Cognition Disorders - drug therapy | Cognitive Dysfunction - etiology | Cognitive Dysfunction - physiopathology | Parkinson Disease - physiopathology | Disease Progression | Neuropsychological Tests | Aged | Antiparkinson Agents - administration & dosage | Drug Combinations | Complications and side effects | Parkinson's disease | Patient outcomes | Dosage and administration | Research | Dopa | Drug therapy
Journal Article
Movement Disorders, ISSN 0885-3185, 12/2014, Volume 29, Issue 14, pp. 1825 - 1828
Background A recent genome‐wide association study (GWAS) has identified a putative association, not statistically confirmed, of cervical dystonia within...
replication | cervical dystonia | GWAS | primary dystonia | association study | Association study | Primary dystonia | Replication | Cervical dystonia | CHANNEL | MUTATIONS | CLINICAL NEUROLOGY | Gene Frequency - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | European Continental Ancestry Group | Genotype | Risk | Case-Control Studies | Dystonia - genetics | Age of Onset | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genome-Wide Association Study - methods
replication | cervical dystonia | GWAS | primary dystonia | association study | Association study | Primary dystonia | Replication | Cervical dystonia | CHANNEL | MUTATIONS | CLINICAL NEUROLOGY | Gene Frequency - genetics | Genetic Predisposition to Disease | Humans | Middle Aged | European Continental Ancestry Group | Genotype | Risk | Case-Control Studies | Dystonia - genetics | Age of Onset | Polymorphism, Single Nucleotide - genetics | Adult | Female | Aged | Genome-Wide Association Study - methods
Journal Article
Neurological Sciences, ISSN 1590-1874, 2/2015, Volume 36, Issue 2, pp. 275 - 279
Drooling is a common symptom in parkinsonian disorders. Our aim was to assess the safety and effect of botulinum toxin when applied to parotid glands without...
Neurology | Parkinsonian disorders | Medicine & Public Health | Neurosurgery | Psychiatry | Botulinum toxin | Neuroradiology | Parkinson’s disease | Sialorrhea | CRITERIA | DIAGNOSIS | Parkinson's disease | EFFICACY | SAFETY | AMYOTROPHIC-LATERAL-SCLEROSIS | NEUROSCIENCES | CLINICAL NEUROLOGY | TRIAL | DISEASE | DOUBLE-BLIND | INJECTIONS | Parotid Gland - drug effects | Parkinsonian Disorders - physiopathology | Follow-Up Studies | Humans | Male | Treatment Outcome | Botulinum Toxins, Type A - administration & dosage | Sialorrhea - drug therapy | Sialorrhea - physiopathology | Peripheral Nervous System Agents - administration & dosage | Time Factors | Parkinsonian Disorders - drug therapy | Peripheral Nervous System Agents - adverse effects | Female | Aged | Retrospective Studies | Botulinum Toxins, Type A - adverse effects
Neurology | Parkinsonian disorders | Medicine & Public Health | Neurosurgery | Psychiatry | Botulinum toxin | Neuroradiology | Parkinson’s disease | Sialorrhea | CRITERIA | DIAGNOSIS | Parkinson's disease | EFFICACY | SAFETY | AMYOTROPHIC-LATERAL-SCLEROSIS | NEUROSCIENCES | CLINICAL NEUROLOGY | TRIAL | DISEASE | DOUBLE-BLIND | INJECTIONS | Parotid Gland - drug effects | Parkinsonian Disorders - physiopathology | Follow-Up Studies | Humans | Male | Treatment Outcome | Botulinum Toxins, Type A - administration & dosage | Sialorrhea - drug therapy | Sialorrhea - physiopathology | Peripheral Nervous System Agents - administration & dosage | Time Factors | Parkinsonian Disorders - drug therapy | Peripheral Nervous System Agents - adverse effects | Female | Aged | Retrospective Studies | Botulinum Toxins, Type A - adverse effects
Journal Article
Bipolar Disorders, ISSN 1398-5647, 05/2016, Volume 18, Issue 3, pp. 261 - 271
Objectives Euthymic patients with bipolar disorder (BD) have deficits in cortical inhibition. However, whether cortical inhibitory deficits are trait‐ or...
longitudinal study | motor cortex | cortical inhibition | GABA receptors | transcallosal inhibition | short‐interval intracortical inhibition | Cortical inhibition | Short-interval intracortical inhibition | Motor cortex | Transcallosal inhibition | Longitudinal study | ABNORMALITIES | PSYCHIATRY | short-interval intracortical inhibition | SCHIZOPHRENIA | MECHANISMS | SMOKING | IMPULSIVITY | NEUROSCIENCES | CLINICAL NEUROLOGY | GABA(A) | TRANSCRANIAL MAGNETIC STIMULATION | INTERHEMISPHERIC INHIBITION | SYSTEMS | RATING-SCALE | Interneurons - physiology | Motor Activity - physiology | Character | Corpus Callosum - physiopathology | Humans | Middle Aged | Bipolar Disorder - physiopathology | Male | Bipolar Disorder - diagnosis | Bipolar Disorder - psychology | Cerebral Cortex - physiopathology | gamma-Aminobutyric Acid - physiology | Young Adult | Neural Inhibition - physiology | Transcranial Direct Current Stimulation | Adult | Female | Longitudinal Studies | Mania | GABA | Bipolar disorder | Analysis
longitudinal study | motor cortex | cortical inhibition | GABA receptors | transcallosal inhibition | short‐interval intracortical inhibition | Cortical inhibition | Short-interval intracortical inhibition | Motor cortex | Transcallosal inhibition | Longitudinal study | ABNORMALITIES | PSYCHIATRY | short-interval intracortical inhibition | SCHIZOPHRENIA | MECHANISMS | SMOKING | IMPULSIVITY | NEUROSCIENCES | CLINICAL NEUROLOGY | GABA(A) | TRANSCRANIAL MAGNETIC STIMULATION | INTERHEMISPHERIC INHIBITION | SYSTEMS | RATING-SCALE | Interneurons - physiology | Motor Activity - physiology | Character | Corpus Callosum - physiopathology | Humans | Middle Aged | Bipolar Disorder - physiopathology | Male | Bipolar Disorder - diagnosis | Bipolar Disorder - psychology | Cerebral Cortex - physiopathology | gamma-Aminobutyric Acid - physiology | Young Adult | Neural Inhibition - physiology | Transcranial Direct Current Stimulation | Adult | Female | Longitudinal Studies | Mania | GABA | Bipolar disorder | Analysis
Journal Article
Movement Disorders, ISSN 0885-3185, 07/2014, Volume 29, Issue 8, pp. 1083 - 1086
Background A polymorphism in brain‐derived neurotrophic factor (BDNF) (Val66Met) has been reported as a risk factor in primary dystonia. However, overall the...
Primary dystonia | meta‐analysis | Val66Met | BDNF | association study | Association study | Meta-analysis | POPULATION | meta-analysis | CRANIAL-CERVICAL DYSTONIA | CLINICAL NEUROLOGY | NEUROTROPHIC FACTOR GENE | VA166MET POLYMORPHISM | COMMON POLYMORPHISM | DISEASE | ASSOCIATION | PLASTICITY | Brain-Derived Neurotrophic Factor - genetics | Dystonic Disorders - genetics | Genetic Predisposition to Disease - genetics | Genetic Association Studies | Gene Frequency | Humans | Middle Aged | Genotype | Male | Case-Control Studies | Polymorphism, Single Nucleotide - genetics | Adult | Female | Valine - genetics | Aged | Methionine - genetics
Primary dystonia | meta‐analysis | Val66Met | BDNF | association study | Association study | Meta-analysis | POPULATION | meta-analysis | CRANIAL-CERVICAL DYSTONIA | CLINICAL NEUROLOGY | NEUROTROPHIC FACTOR GENE | VA166MET POLYMORPHISM | COMMON POLYMORPHISM | DISEASE | ASSOCIATION | PLASTICITY | Brain-Derived Neurotrophic Factor - genetics | Dystonic Disorders - genetics | Genetic Predisposition to Disease - genetics | Genetic Association Studies | Gene Frequency | Humans | Middle Aged | Genotype | Male | Case-Control Studies | Polymorphism, Single Nucleotide - genetics | Adult | Female | Valine - genetics | Aged | Methionine - genetics
Journal Article
Journal of Neurology, ISSN 0340-5354, 09/2013, Volume 260, Issue 9, pp. 2237 - 2241
Parkinson's disease (PD) is a neurodegenerative disease caused by both genetic and environmental factors. Sirtuins are highly-conserved, NAD-dependent class...
Sirtuins | Parkinson's disease | Polymorphism | LONGEVITY | MODELS | PGC-1-ALPHA | MICE | MUTATIONS | DAMAGE | BRAIN | CLINICAL NEUROLOGY | PROTECTS | Genetic Predisposition to Disease - genetics | Humans | Middle Aged | Genotype | Polymorphism, Single Nucleotide | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Parkinson Disease - genetics | Sirtuins - genetics | Genetic aspects | MicroRNA | Single nucleotide polymorphisms | Health aspects | Risk factors | Animal models
Sirtuins | Parkinson's disease | Polymorphism | LONGEVITY | MODELS | PGC-1-ALPHA | MICE | MUTATIONS | DAMAGE | BRAIN | CLINICAL NEUROLOGY | PROTECTS | Genetic Predisposition to Disease - genetics | Humans | Middle Aged | Genotype | Polymorphism, Single Nucleotide | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Parkinson Disease - genetics | Sirtuins - genetics | Genetic aspects | MicroRNA | Single nucleotide polymorphisms | Health aspects | Risk factors | Animal models
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2016, Volume 377, pp. 161 - 166
Abstract Introduction Vascular parkinsonism is a syndrome that develops as a result of cerebrovascular disease. Although several studies on clinical features...
Neurology | Long term potentiation | Parkinson's disease | Cognitive function | Vascular parkinsonism | Plasticity | Neurophysiology | LATENCY AFFERENT INHIBITION | CLINICAL-FEATURES | NEUROSCIENCES | CLINICAL NEUROLOGY | IMPAIRMENT | CIRCUITS | HUMAN MOTOR CORTEX | TRANSCRANIAL MAGNETIC STIMULATION | EXCITABILITY | FUNCTIONAL-EVALUATION | DISEASE | Cerebrovascular Disorders - physiopathology | Neural Inhibition | Humans | Afferent Pathways - physiopathology | Male | Cognition | Evoked Potentials, Somatosensory | Sensorimotor Cortex - physiopathology | Neuropsychological Tests | Transcranial Magnetic Stimulation | Evoked Potentials, Motor | Neuronal Plasticity | Median Nerve - physiopathology | Muscle, Skeletal - physiopathology | Parkinson Disease, Secondary - physiopathology | Parkinson Disease, Secondary - psychology | Aged, 80 and over | Female | Aged | Electromyography | Cerebrovascular Disorders - psychology | Medicine, Experimental | Medical research | Executives
Neurology | Long term potentiation | Parkinson's disease | Cognitive function | Vascular parkinsonism | Plasticity | Neurophysiology | LATENCY AFFERENT INHIBITION | CLINICAL-FEATURES | NEUROSCIENCES | CLINICAL NEUROLOGY | IMPAIRMENT | CIRCUITS | HUMAN MOTOR CORTEX | TRANSCRANIAL MAGNETIC STIMULATION | EXCITABILITY | FUNCTIONAL-EVALUATION | DISEASE | Cerebrovascular Disorders - physiopathology | Neural Inhibition | Humans | Afferent Pathways - physiopathology | Male | Cognition | Evoked Potentials, Somatosensory | Sensorimotor Cortex - physiopathology | Neuropsychological Tests | Transcranial Magnetic Stimulation | Evoked Potentials, Motor | Neuronal Plasticity | Median Nerve - physiopathology | Muscle, Skeletal - physiopathology | Parkinson Disease, Secondary - physiopathology | Parkinson Disease, Secondary - psychology | Aged, 80 and over | Female | Aged | Electromyography | Cerebrovascular Disorders - psychology | Medicine, Experimental | Medical research | Executives
Journal Article
Movement Disorders, ISSN 0885-3185, 03/2016, Volume 31, Issue 3, pp. 402 - 405
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2014, Volume 35, Issue 3, pp. 727.e5 - 727.e7
Abstract Mutations in FBXO7 (PARK15) have been associated with a syndrome characterized by early-onset progressive parkinsonism with and without pyramidal...
Neurology | Internal Medicine | Parkinsonism | Variants | Parkinson's disease | Early-onset | Mutational analysis | FBXO7 | Pyramidal signs | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | Spain - epidemiology | Humans | Age of Onset | Parkinson Disease - epidemiology | Mutation | Parkinson Disease - genetics | DNA Mutational Analysis - methods | F-Box Proteins - genetics
Neurology | Internal Medicine | Parkinsonism | Variants | Parkinson's disease | Early-onset | Mutational analysis | FBXO7 | Pyramidal signs | NEUROSCIENCES | GERIATRICS & GERONTOLOGY | Spain - epidemiology | Humans | Age of Onset | Parkinson Disease - epidemiology | Mutation | Parkinson Disease - genetics | DNA Mutational Analysis - methods | F-Box Proteins - genetics
Journal Article
Journal of Neurology, ISSN 0340-5354, 3/2014, Volume 261, Issue 3, pp. 561 - 569
The short-term benefits of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced Parkinson’s disease (PD) are well documented, but the long-term...
Neurology | Neurosciences | Medicine & Public Health | LCIG | Long-term | Neuroradiology | Advanced Parkinson’s disease
Neurology | Neurosciences | Medicine & Public Health | LCIG | Long-term | Neuroradiology | Advanced Parkinson’s disease
Journal Article